EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/23/2025
Back to search
Official data from USPTO
ZAGBEMIZ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
01/28/2025
Trademark type
Word
Nice classes
5
Filing date
01/03/2024
Registration date
01/14/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/14/2025
Last transaction
01/28/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
WUXI CITY, CN
Examiner
RUIZ SANTIAGO,REBECCA E
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
JIANGSU BIOJETAY BIOTECHNOLOGY CO., LTD.
Staidson (Beijing) Biopharmaceuticals Co., Ltd.
Representatives
Jonathan M. Rixen Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for human purposesmedicines for the treatment of cancercardiovascular diseaseshematologic diseasesneurological diseasesgastrointestinal and genetic diseasesinflammatory diseasesautoimmune diseasesinfectious diseasescoagulation disordersinfectious and parasitic diseasesneoplasmsdiseases of the blood and blood-forming organsendocrinenutritional and metabolic diseasesmentalbehavioral and neurodevelopmental disorderssleep-wake disordersdiseases of the nervous systemdiseases of the respiratory systemdiseases of the digestive systemdiseases of the skincongenital bleeding disorders and acquired bleeding disordersdisorders due to a deficiency of a coagulation factordisorders due to the presence of acquired inhibitors to a coagulation factorhematologic disordershemorrhagic disordersVon Willebrands' diseasedisorders resulting from anticoagulant therapy with a vitamin-K antagonisthereditary platelet disordersvitamin K epoxide reductase C1 deficiencygamma-carboxylase deficiencybleeding associated with traumainjurysurgerythrombosisthrombocytopeniastrokecoagulopathydisseminated intravascular coagulation (DIC)Bernard Soulier syndromeGlanzman thromblastemiastorage pool deficiencyhemophilia; pharmaceutical preparations and substances for the treatment of viral diseasesmetabolic diseasesendocrine diseasesmusculoskeletal diseasescardiovascular diseaseshematologic diseasescardiopulmonary diseasesgenitourinary diseasessexual dysfunctiononcological diseaseshepatological diseasesophthalmic diseasesrespiratory diseasesneurological diseasesgastrointestinal diseaseshormonal diseasesdermatological diseasescoagulation disordersdiseases of the blood and blood-forming organspsychiatric and immune system related diseases and disorderscongenital bleeding disorders and acquired bleeding disordersdisorders due to a deficiency of a coagulation factordisorders due to the presence of acquired inhibitors to a coagulation factorhematologic disordershemorrhagic disordersVon Willebrands' diseasedisorders resulting from anticoagulant therapy with a vitamin-K antagonisthereditary platelet disordersvitamin K epoxide reductase C1 deficiencygamma-carboxylase deficiencybleeding associated with traumainjurysurgerythrombosisthrombocytopeniastrokecoagulopathydisseminated intravascular coagulation (DIC)Bernard Soulier syndromeGlanzman thromblastemiastorage pool deficiencyhemophilia; diagnostic preparations for medical purposes; dietetic foods and beverages adapted for medical use; depuratives for the body; veterinary pharmaceutical compounds for equine use to treat conditions of the leghoofearnose and throat; pesticides; first aid kits; dental abrasives.
Publications
History of USPTO decisions and trademark events.
15 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/23/2025
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
01/23/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/23/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/23/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/14/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
01/14/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/11/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/17/2024
PUBO
PUBLISHED FOR OPPOSITION
09/17/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/28/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/09/2024
DOCK
ASSIGNED TO EXAMINER
07/30/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/18/2024
NWAP
NEW APPLICATION ENTERED
01/03/2024
Continuous trademark protection
Get notified about every new filing that threatens ZAGBEMIZ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.